Altimmune, Inc.: insider trading
493 trades by 48 directors, officers and 10% owners since 2010, from their SEC Form 4 and 5 filings.
Bought, 12 months
$467 K
15 purchases by 7 insiders
Sold, 12 months
$0
0 sales by 0 insiders
Bought, 3 months
$96 K
4 purchases
Sold, 3 months
$0
0 sales
Insider buying and selling by month
Open-market purchases and sales by value, last three years.
Insiders (48)
Each insider's latest direct holding and their open-market trades of the last 12 months, most recent first.
| Insider | Shares owned directly | Bought, 12 m | Sold, 12 m | Latest trade |
|---|---|---|---|---|
| Richard Thomas MenziusoPrincipal Accounting Officer | 10,000 | $14 K | — | |
| Gregory L. WeaverChief Financial Officer | 73,005 | $65 K | — | |
| Jerome Benedict DursoPresident and CEO, Director | 93,200 | $263 K | — | |
| Wayne PisanoDirector | 58,800 | $37 K | — | |
| Christophe Arbet-EngelsChief Medical Officer | 24,821 | — | — | |
| Linda M. RichardsonChief Commercial Officer | 17,174 | — | — | |
| M. Scot RobertsChief Scientific Officer | 113,699 | — | — | |
| John GillDirector | 21,700 | $83 K | — | |
| Raymond M. JordtChief Business Officer | 70,107 | — | — | |
| Vipin K. GargDirector | 424,519 | — | — | |
| Catherine A. SohnDirector | 1,500 | $2 K | — | |
| Diane JorkaskyDirector | 527 | $2 K | — | |
| Matthew Scott HarrisChief Medical Officer | 16,087 | — | — | |
| David DrutzDirector | 20,151 | — | — | |
| Andrew ShutterlyActing Chief Financial Officer | 11,372 | — | — | |
| Richard I. EisenstadtChief Financial Officer | 45,012 | — | — | |
| Klaus SchaferDirector | 9,179 | — | — | |
| William Michael BrownChief Financial Officer | 17,721 | — | — | |
| Philip HodgesDirector | 8,731 | — | — | |
| VHCP Management III, LLC10% owner | — | — | — | |
| Mitchel SayareDirector | 26,363 | — | — | |
| VHCP Co-Investment Holdings II, LLC10% owner | — | — | — | |
| Velocity Pharmaceutical Holdings LLC10% owner | 1.69 M | — | — | |
| Novartis Bioventures Ltd10% owner | — | — | — | |
| Ag Novartis10% owner | — | — | — | |
| William EnrightPresident and CEO, Director | 365,839 | — | — | |
| Capital S.a.s. Truffle10% owner | — | — | — | |
| Derace L. SchafferDirector | 589,453 | — | — | |
| Redmont Venture Partners, Inc.10% owner | — | — | — | |
| Jeffrey W. RungeDirector | 197,700 | — | — | |
| Steven St PeterDirector | 205,004 | — | — | |
| Philip MacneillVP, CFO, Treasurer, Secretary | 126,346 | — | — | |
| Prescott Group Capital Management, L.L.C.10% owner | — | — | — | |
| Eric I. RichmanDirector | 898,055 | — | — | |
| Jeffrey Michael JonesCOO | 27,544 | — | — | |
| Linda L. ChangSVP, CFO & Secretary | 30,000 | — | — | |
| Francesca M. CookSVP, Policy & Gov't Affairs | 37,631 | — | — | |
| Jordan P. KarpSVP, General Counsel | 21,929 | — | — | |
| Thomas Richard FuerstSVP, Chief Scientific Officer | 15,000 | — | — | |
| Valerie D. RiddleSVP, Medical Director | 44,436 | — | — | |
| John PappajohnDirector | 911,164 | — | — | |
| James H. CavanaughDirector, 10% owner | — | — | — | |
| Joel McClearyDirector | 120,167 | — | — | |
| MPM Bioventures III LLC10% owner | — | — | — | |
| Nicholas J. Simon III10% owner | — | — | — | |
| Joan FuscoSenior VP, Operations | 36,730 | — | — | |
| Christopher C. CamutVP, Gov't Contracts | 46,777 | — | — | |
| Wayne MorgesVP, Regulatory Affairs & Qual | 35,532 | — | — |
Trades#
The newest 300 trades.
| Traded | Insider | Trade | Shares | Price | Value | Owned after | Filing |
|---|---|---|---|---|---|---|---|
| filed | Richard Thomas MenziusoPrincipal Accounting Officer | Buy | +10,000 | $1.419 | $14 K | 10,000 | Form 4 |
| filed | Gregory L. WeaverChief Financial Officer | Buy | +10,000 | $1.620 | $16 K | 73,005 | Form 4 |
| filed | Jerome Benedict DursoPresident and CEO, Director | Buy | +30,700 | $1.619 | $50 K | 93,200 | Form 4 |
| filed | Wayne PisanoDirector | Buy | +10,000 | $1.635 | $16 K | 58,800 | Form 4 |
| filed | Gregory L. WeaverChief Financial Officer | Option exercise | +18,750 | — | — | 68,677 | Form 4 |
| filed | Gregory L. WeaverChief Financial Officer | Shares withheld for tax | -5,672 | $1.930 | $11 K | 63,005 | Form 4 |
| filed | Christophe Arbet-EngelsChief Medical Officer | Option exercise | +37,500 | — | — | 37,500 | Form 4 |
| filed | Gregory L. WeaverChief Financial Officer | Option exercise | +14,475 | — | — | 54,306 | Form 4 |
| filed | Gregory L. WeaverChief Financial Officer | Shares withheld for tax | -4,379 | $2.760 | $12 K | 49,927 | Form 4 |
| filed | Christophe Arbet-EngelsChief Medical Officer | Shares withheld for tax | -12,679 | $2.760 | $35 K | 24,821 | Form 4 |
| filed | Linda M. RichardsonChief Commercial Officer | Option exercise | +24,000 | — | — | 24,000 | Form 4 |
| filed | Linda M. RichardsonChief Commercial Officer | Shares withheld for tax | -6,826 | $3.240 | $22 K | 17,174 | Form 4 |
| filed | Jerome Benedict DursoPresident and CEO, Director | Buy | +15,000 | $2.950 | $44 K | 62,500 | Form 4 |
| filed | M. Scot RobertsChief Scientific Officer | Grant or award | +875 | $2.410 | $2 K | 113,699 | Form 4 |
| filed | Gregory L. WeaverChief Financial Officer | Grant or award | +1,753 | $2.410 | $4 K | 39,831 | Form 4 |
| filed | John GillDirector | Buy | +9,200 | $3.410 | $31 K | 21,700 | Form 4 |
| filed | Gregory L. WeaverChief Financial Officer | Buy | +10,000 | $3.150 | $32 K | 38,078 | Form 4 |
| filed | Jerome Benedict DursoPresident and CEO, Director | Buy | +15,000 | $3.140 | $47 K | 47,500 | Form 4 |
| filed | Jerome Benedict DursoPresident and CEO, Director | Buy | +20,000 | $3.540 | $71 K | 32,500 | Form 4 |
| filed | Gregory L. WeaverChief Financial Officer | Buy | +5,000 | $3.540 | $18 K | 28,078 | Form 4 |
| filed | M. Scot RobertsChief Scientific Officer | Option exercise | +7,775 | — | — | 115,153 | Form 4 |
| filed | M. Scot RobertsChief Scientific Officer | Shares withheld for tax | -2,329 | $5.550 | $13 K | 112,824 | Form 4 |
| filed | M. Scot RobertsChief Scientific Officer | Grant or award | +5,567 | $3.070 | $17 K | 107,378 | Form 4 |
| filed | Raymond M. JordtChief Business Officer | Grant or award | +4,571 | $3.070 | $14 K | 70,107 | Form 4 |
| filed | Vipin K. GargDirector | Grant or award | +6,926 | $3.070 | $21 K | 424,519 | Form 4 |
| filed | M. Scot RobertsChief Scientific Officer | Option exercise | +9,275 | — | — | 104,670 | Form 4 |
| filed | M. Scot RobertsChief Scientific Officer | Shares withheld for tax | -2,859 | $5.600 | $16 K | 101,811 | Form 4 |
| filed | Vipin K. GargDirector | Option exercise | +26,775 | — | — | 429,225 | Form 4 |
| filed | Vipin K. GargDirector | Shares withheld for tax | -11,632 | $5.600 | $65 K | 417,593 | Form 4 |
| filed | Raymond M. JordtChief Business Officer | Option exercise | +15,850 | — | — | 69,765 | Form 4 |
| filed | Vipin K. GargDirector | Option exercise | +41,200 | — | — | 420,348 | Form 4 |
| filed | M. Scot RobertsChief Scientific Officer | Option exercise | +15,850 | — | — | 100,143 | Form 4 |
| filed | Raymond M. JordtChief Business Officer | Shares withheld for tax | -4,229 | $6.180 | $26 K | 65,536 | Form 4 |
| filed | M. Scot RobertsChief Scientific Officer | Shares withheld for tax | -4,748 | $6.180 | $29 K | 95,395 | Form 4 |
| filed | Vipin K. GargDirector | Shares withheld for tax | -17,898 | $6.180 | $111 K | 402,450 | Form 4 |
| filed | Raymond M. JordtChief Business Officer | Option exercise | +14,600 | — | — | 57,770 | Form 4 |
| filed | M. Scot RobertsChief Scientific Officer | Option exercise | +14,600 | — | — | 88,666 | Form 4 |
| filed | Vipin K. GargDirector | Option exercise | +42,050 | — | — | 397,132 | Form 4 |
| filed | Vipin K. GargDirector | Shares withheld for tax | -17,984 | $5.500 | $99 K | 379,148 | Form 4 |
| filed | Raymond M. JordtChief Business Officer | Shares withheld for tax | -3,855 | $5.500 | $21 K | 53,915 | Form 4 |
| filed | M. Scot RobertsChief Scientific Officer | Shares withheld for tax | -4,373 | $5.500 | $24 K | 84,293 | Form 4 |
| filed | Wayne PisanoDirector | Buy | +5,000 | $4.080 | $20 K | 13,498 | Form 4 |
| filed | Catherine A. SohnDirector | Buy | +500 | $4.240 | $2 K | 1,500 | Form 4 |
| filed | Raymond M. JordtChief Business Officer | Option exercise | +9,375 | — | — | 45,645 | Form 4 |
| filed | Raymond M. JordtChief Business Officer | Shares withheld for tax | -2,475 | $3.610 | $9 K | 43,170 | Form 4 |
| filed | Diane JorkaskyDirector | Buy | +527 | $3.800 | $2 K | 527 | Form 4 |
| filed | John GillDirector | Buy | +12,500 | $4.100 | $51 K | 12,500 | Form 4 |
| filed | Jerome Benedict DursoDirector | Buy | +12,500 | $4.130 | $52 K | 12,500 | Form 4 |
| filed | Gregory L. WeaverChief Financial Officer | Option exercise | +18,750 | — | — | 28,750 | Form 4 |
| filed | Gregory L. WeaverChief Financial Officer | Shares withheld for tax | -5,672 | $4.280 | $24 K | 23,078 | Form 4 |
| filed | Matthew Scott HarrisChief Medical Officer | Grant or award | +2,018 | $3.140 | $6 K | 16,087 | Form 4 |
| filed | Raymond M. JordtChief Business Officer | Grant or award | +1,368 | $3.140 | $4 K | 36,270 | Form 4 |
| filed | M. Scot RobertsChief Scientific Officer | Grant or award | +846 | $3.140 | $3 K | 74,066 | Form 4 |
| filed | Catherine A. SohnDirector | Buy | +1,000 | $5.780 | $6 K | 1,000 | Form 4 |
| filed | Gregory L. WeaverChief Financial Officer | Buy | +10,000 | $5.200 | $52 K | 10,000 | Form 4 |
| filed | Matthew Scott HarrisChief Medical Officer | Gift | -67,787 | — | — | 14,069 | Form 4 |
| filed | Vipin K. GargPresident and CEO, Director | Option exercise | +18,950 | — | — | 363,364 | Form 4 |
| filed | Matthew Scott HarrisChief Medical Officer | Option exercise | +7,775 | — | — | 84,564 | Form 4 |
| filed | M. Scot RobertsChief Scientific Officer | Option exercise | +7,775 | — | — | 75,536 | Form 4 |
| filed | Vipin K. GargPresident and CEO, Director | Shares withheld for tax | -8,282 | $6.640 | $55 K | 355,082 | Form 4 |
| filed | M. Scot RobertsChief Scientific Officer | Shares withheld for tax | -2,316 | $6.640 | $15 K | 73,220 | Form 4 |
| filed | Matthew Scott HarrisChief Medical Officer | Shares withheld for tax | -2,708 | $6.640 | $18 K | 81,856 | Form 4 |
| filed | Vipin K. GargPresident and CEO, Director | Option exercise | +16,545 | — | — | 351,645 | Form 4 |
| filed | Matthew Scott HarrisChief Medical Officer | Option exercise | +6,166 | — | — | 78,898 | Form 4 |
| filed | M. Scot RobertsChief Scientific Officer | Option exercise | +6,166 | — | — | 69,562 | Form 4 |
| filed | Vipin K. GargPresident and CEO, Director | Shares withheld for tax | -7,231 | $6.640 | $48 K | 344,414 | Form 4 |
| filed | Matthew Scott HarrisChief Medical Officer | Shares withheld for tax | -2,109 | $6.640 | $14 K | 76,789 | Form 4 |
| filed | M. Scot RobertsChief Scientific Officer | Shares withheld for tax | -1,801 | $6.640 | $12 K | 67,761 | Form 4 |
| filed | Raymond M. JordtChief Business Officer | Grant or award | +2,614 | $5.180 | $14 K | 34,902 | Form 4 |
| filed | M. Scot RobertsChief Scientific Officer | Grant or award | +3,184 | $5.180 | $16 K | 63,396 | Form 4 |
| filed | Matthew Scott HarrisChief Medical Officer | Grant or award | +1,905 | $5.180 | $10 K | 72,732 | Form 4 |
| filed | Vipin K. GargPresident and CEO, Director | Grant or award | +4,105 | $5.180 | $21 K | 335,100 | Form 4 |
| filed | Matthew Scott HarrisChief Medical Officer | Option exercise | +9,275 | — | — | 74,000 | Form 4 |
| filed | M. Scot RobertsChief Scientific Officer | Option exercise | +9,275 | — | — | 62,921 | Form 4 |
| filed | Vipin K. GargPresident and CEO, Director | Option exercise | +26,775 | — | — | 342,696 | Form 4 |
| filed | M. Scot RobertsChief Scientific Officer | Shares withheld for tax | -2,709 | $7.000 | $19 K | 60,212 | Form 4 |
| filed | Matthew Scott HarrisChief Medical Officer | Shares withheld for tax | -3,173 | $7.000 | $22 K | 70,827 | Form 4 |
| filed | Vipin K. GargPresident and CEO, Director | Shares withheld for tax | -11,701 | $7.000 | $82 K | 330,995 | Form 4 |
| filed | Raymond M. JordtChief Business Officer | Option exercise | +14,600 | — | — | 36,150 | Form 4 |
| filed | Vipin K. GargPresident and CEO, Director | Option exercise | +42,050 | — | — | 334,078 | Form 4 |
| filed | M. Scot RobertsChief Scientific Officer | Option exercise | +14,600 | — | — | 57,910 | Form 4 |
| filed | Matthew Scott HarrisChief Medical Officer | Option exercise | +14,600 | — | — | 69,719 | Form 4 |
| filed | Matthew Scott HarrisChief Medical Officer | Shares withheld for tax | -4,994 | $6.980 | $35 K | 64,725 | Form 4 |
| filed | Raymond M. JordtChief Business Officer | Shares withheld for tax | -3,862 | $6.980 | $27 K | 32,288 | Form 4 |
| filed | M. Scot RobertsChief Scientific Officer | Shares withheld for tax | -4,264 | $6.980 | $30 K | 53,646 | Form 4 |
| filed | Vipin K. GargPresident and CEO, Director | Shares withheld for tax | -18,157 | $6.980 | $127 K | 315,921 | Form 4 |
| filed | Raymond M. JordtChief Business Officer | Option exercise | +9,375 | — | — | 24,035 | Form 4 |
| filed | Raymond M. JordtChief Business Officer | Shares withheld for tax | -2,485 | $7.210 | $18 K | 21,550 | Form 4 |
| filed | David DrutzDirector | Option exerciseindirect | +20,000 | $2.600 | $52 K | 49,785 | Form 4 |
| filed | David DrutzDirector | Sellindirect | -7,827 | $6.930 | $54 K | 41,958 | Form 4 |
| filed | David DrutzDirector | Option exerciseindirect | +21,750 | $2.500 | $54 K | 63,708 | Form 4 |
| filed | David DrutzDirector | Sellindirect | -8,184 | $6.880 | $56 K | 55,524 | Form 4 |
| filed | Andrew ShutterlyActing Chief Financial Officer | Grant or award | +1,259 | $5.410 | $7 K | 11,372 | Form 4 |
| filed | M. Scot RobertsChief Scientific Officer | Grant or award | +650 | $5.410 | $4 K | 43,310 | Form 4 |
| filed | Matthew Scott HarrisChief Medical Officer | Grant or award | +1,486 | $5.410 | $8 K | 55,119 | Form 4 |
| filed | Raymond M. JordtChief Business Officer | Grant or award | +917 | $5.410 | $5 K | 14,660 | Form 4 |
| filed | M. Scot RobertsChief Scientific Officer | Option exercise | +7,775 | — | — | 44,990 | Form 4 |
| filed | Matthew Scott HarrisChief Medical Officer | Option exercise | +7,775 | — | — | 55,965 | Form 4 |
| filed | Vipin K. GargPresident and CEO, Director | Option exercise | +18,950 | — | — | 300,404 | Form 4 |
| filed | M. Scot RobertsChief Scientific Officer | Shares withheld for tax | -2,330 | $9.320 | $22 K | 42,660 | Form 4 |
| filed | Matthew Scott HarrisChief Medical Officer | Shares withheld for tax | -2,332 | $9.320 | $22 K | 53,633 | Form 4 |
| filed | Vipin K. GargPresident and CEO, Director | Shares withheld for tax | -8,376 | $9.320 | $78 K | 292,028 | Form 4 |
| filed | M. Scot RobertsChief Scientific Officer | Option exercise | +6,166 | — | — | 39,016 | Form 4 |
| filed | Matthew Scott HarrisChief Medical Officer | Option exercise | +6,166 | — | — | 49,991 | Form 4 |
| filed | Vipin K. GargPresident and CEO, Director | Option exercise | +16,545 | — | — | 288,767 | Form 4 |
| filed | Matthew Scott HarrisChief Medical Officer | Shares withheld for tax | -1,801 | $9.880 | $18 K | 48,190 | Form 4 |
| filed | M. Scot RobertsChief Scientific Officer | Shares withheld for tax | -1,801 | $9.880 | $18 K | 37,215 | Form 4 |
| filed | Vipin K. GargPresident and CEO, Director | Shares withheld for tax | -7,313 | $9.880 | $72 K | 281,454 | Form 4 |
| filed | Raymond M. JordtChief Business Officer | Grant or award | +5,030 | $2.690 | $14 K | 13,743 | Form 4 |
| filed | Matthew Scott HarrisChief Medical Officer | Grant or award | +3,257 | $2.690 | $9 K | 43,825 | Form 4 |
| filed | M. Scot RobertsChief Scientific Officer | Grant or award | +5,860 | $2.690 | $16 K | 32,850 | Form 4 |
| filed | Richard I. EisenstadtChief Financial Officer | Grant or award | +4,621 | $2.690 | $12 K | 45,012 | Form 4 |
| filed | Vipin K. GargPresident and CEO, Director | Grant or award | +7,889 | $2.690 | $21 K | 272,222 | Form 4 |
| filed | M. Scot RobertsChief Scientific Officer | Option exercise | +9,275 | — | — | 29,699 | Form 4 |
| filed | Richard I. EisenstadtChief Financial Officer | Option exercise | +9,275 | — | — | 42,566 | Form 4 |
| filed | Matthew Scott HarrisChief Medical Officer | Option exercise | +9,275 | — | — | 43,277 | Form 4 |
| filed | Vipin K. GargPresident and CEO, Director | Option exercise | +26,775 | — | — | 276,030 | Form 4 |
| filed | Richard I. EisenstadtChief Financial Officer | Shares withheld for tax | -2,175 | $9.800 | $21 K | 40,391 | Form 4 |
| filed | M. Scot RobertsChief Scientific Officer | Shares withheld for tax | -2,709 | $9.800 | $27 K | 26,990 | Form 4 |
| filed | Matthew Scott HarrisChief Medical Officer | Shares withheld for tax | -2,709 | $9.800 | $27 K | 40,568 | Form 4 |
| filed | Vipin K. GargPresident and CEO, Director | Shares withheld for tax | -11,697 | $9.800 | $115 K | 264,333 | Form 4 |
| filed | Raymond M. JordtChief Business Officer | Option exercise | +9,375 | — | — | 11,207 | Form 4 |
| filed | Raymond M. JordtChief Business Officer | Shares withheld for tax | -2,503 | $11.25 | $28 K | 8,704 | Form 4 |
| filed | Richard I. EisenstadtChief Financial Officer | Option exercise | +12,500 | — | — | 36,335 | Form 4 |
| filed | Richard I. EisenstadtChief Financial Officer | Shares withheld for tax | -3,044 | $11.25 | $34 K | 33,291 | Form 4 |
| filed | David DrutzDirector | Buyindirect | +300 | $2.880 | $864 | 29,785 | Form 4 |
| filed | M. Scot RobertsChief Scientific Officer | Grant or award | +568 | $2.810 | $2 K | 20,424 | Form 4 |
| filed | Raymond M. JordtChief Business Officer | Grant or award | +1,832 | $2.810 | $5 K | 1,832 | Form 4 |
| filed | Matthew Scott HarrisChief Medical Officer | Grant or award | +691 | $2.810 | $2 K | 34,002 | Form 4 |
| filed | Richard I. EisenstadtChief Financial Officer | Grant or award | +1,825 | $2.810 | $5 K | 23,835 | Form 4 |
| filed | Vipin K. GargPresident and CEO, Director | Grant or award | +126 | $2.810 | $354 | 249,255 | Form 4 |
| filed | Richard I. EisenstadtChief Financial Officer | Buy | +10,000 | $4.310 | $43 K | 22,010 | Form 4 |
| filed | David DrutzDirector | Buyindirect | +9,000 | $4.270 | $38 K | 29,484 | Form 4 |
| filed | Matthew Scott HarrisChief Medical Officer | Buy | +10,000 | $4.220 | $42 K | 33,311 | Form 4 |
| filed | Vipin K. GargPresident and CEO, Director | Option exercise | +18,950 | — | — | 257,551 | Form 4 |
| filed | Matthew Scott HarrisChief Medical Officer | Option exercise | +7,775 | — | — | 25,675 | Form 4 |
| filed | M. Scot RobertsChief Scientific Officer | Option exercise | +7,775 | — | — | 22,231 | Form 4 |
| filed | Vipin K. GargPresident and CEO, Director | Shares withheld for tax | -8,422 | $15.04 | $127 K | 249,129 | Form 4 |
| filed | Matthew Scott HarrisChief Medical Officer | Shares withheld for tax | -2,364 | $15.04 | $36 K | 23,311 | Form 4 |
| filed | M. Scot RobertsChief Scientific Officer | Shares withheld for tax | -2,375 | $15.04 | $36 K | 19,856 | Form 4 |
| filed | M. Scot RobertsChief Scientific Officer | Option exercise | +6,166 | — | — | 16,639 | Form 4 |
| filed | Vipin K. GargPresident and CEO, Director | Option exercise | +16,546 | — | — | 246,259 | Form 4 |
| filed | Matthew Scott HarrisChief Medical Officer | Option exercise | +6,166 | — | — | 20,083 | Form 4 |
| filed | Matthew Scott HarrisChief Medical Officer | Shares withheld for tax | -2,183 | $13.78 | $30 K | 17,900 | Form 4 |
| filed | M. Scot RobertsChief Scientific Officer | Shares withheld for tax | -2,183 | $13.78 | $30 K | 14,456 | Form 4 |
| filed | Vipin K. GargPresident and CEO, Director | Shares withheld for tax | -7,658 | $13.78 | $106 K | 238,601 | Form 4 |
| filed | Matthew Scott HarrisChief Medical Officer | Grant or award | +1,296 | $10.21 | $13 K | 13,917 | Form 4 |
| filed | Vipin K. GargPresident and CEO, Director | Grant or award | +1,938 | $10.21 | $20 K | 229,713 | Form 4 |
| filed | Richard I. EisenstadtChief Financial Officer | Grant or award | +1,172 | $10.21 | $12 K | 12,010 | Form 4 |
| filed | M. Scot RobertsChief Scientific Officer | Grant or award | +1,436 | $10.21 | $15 K | 10,473 | Form 4 |
| filed | Richard I. EisenstadtChief Financial Officer | Option exercise | +12,500 | — | — | 13,866 | Form 4 |
| filed | Richard I. EisenstadtChief Financial Officer | Shares withheld for tax | -3,028 | $16.45 | $50 K | 10,838 | Form 4 |
| filed | Wayne PisanoDirector | Option exercise | +20,000 | $2.600 | $52 K | 28,498 | Form 4 |
| filed | Wayne PisanoDirector | Sell10b5-1 plan | -20,000 | $15.01 | $300 K | 8,498 | Form 4 |
| filed | Vipin K. GargPresident and CEO, Director | Shares withheld for tax | -3,007 | $9.950 | $30 K | 227,775 | Form 4 |
| filed | David DrutzDirector | Option exercise | +139 | $2.400 | $334 | 20,151 | Form 4 |
| filed | Vipin K. GargPresident and CEO, Director | Shares withheld for tax | -3,007 | $12.77 | $38 K | 230,782 | Form 4 |
| filed | Vipin K. GargPresident and CEO, Director | Shares withheld for tax | -3,008 | $12.77 | $38 K | 233,789 | Form 4 |
| filed | Vipin K. GargPresident and CEO, Director | Sell10b5-1 plan | -20,000 | $20.02 | $400 K | 236,797 | Form 4 |
| filed | Vipin K. GargPresident and CEO, Director | Shares withheld for tax | -3,007 | $18.94 | $57 K | 256,797 | Form 4 |
| filed | John GillDirector | Sell | -2,714 | $15.00 | $41 K | 2,771 | Form 4 |
| filed | Vipin K. GargPresident and CEO, Director | Sell10b5-1 plan | -15,000 | $15.06 | $226 K | 259,804 | Form 4 |
| filed | Matthew Scott HarrisChief Medical Officer | Grant or award | +1,076 | $6.860 | $7 K | 12,621 | Form 4 |
| filed | M. Scot RobertsChief Scientific Officer | Grant or award | +732 | $6.860 | $5 K | 9,037 | Form 4 |
| filed | Richard I. EisenstadtChief Financial Officer | Grant or award | +1,366 | $6.860 | $9 K | 1,366 | Form 4 |
| filed | Vipin K. GargPresident and CEO, Director | Shares withheld for tax | -3,007 | $12.01 | $36 K | 274,804 | Form 4 |
| filed | M. Scot RobertsChief Scientific Officer | Option exercise | +787 | $2.950 | $2 K | 18,487 | Form 4 |
| filed | M. Scot RobertsChief Scientific Officer | Sell10b5-1 plan | -10,182 | $12.00 | $122 K | 8,305 | Form 4 |
| filed | M. Scot RobertsChief Scientific Officer | Option exercise | +4,019 | $2.600 | $10 K | 21,719 | Form 4 |
| filed | M. Scot RobertsChief Scientific Officer | Option exercise | +22,963 | $2.950 | $68 K | 44,682 | Form 4 |
| filed | M. Scot RobertsChief Scientific Officer | Sell10b5-1 plan | -26,982 | $12.00 | $324 K | 17,700 | Form 4 |
| filed | Vipin K. GargPresident and CEO, Director | Shares withheld for tax | -3,007 | $11.70 | $35 K | 277,811 | Form 4 |
| filed | M. Scot RobertsChief Scientific Officer | Option exercise | +5,462 | $2.600 | $14 K | 23,162 | Form 4 |
| filed | M. Scot RobertsChief Scientific Officer | Sell10b5-1 plan | -5,462 | $12.00 | $66 K | 17,700 | Form 4 |
| filed | Diane JorkaskyDirector | Option exercise | +17,610 | $3.150 | $55 K | 17,610 | Form 4 |
| filed | M. Scot RobertsChief Scientific Officer | Option exercise | +25,583 | $1.920 | $49 K | 43,283 | Form 4 |
| filed | M. Scot RobertsChief Scientific Officer | Option exercise | +11,769 | $2.600 | $31 K | 55,052 | Form 4 |
| filed | Diane JorkaskyDirector | Sell10b5-1 plan | -17,610 | $11.75 | $207 K | 0 | Form 4 |
| filed | M. Scot RobertsChief Scientific Officer | Sell10b5-1 plan | -37,352 | $12.00 | $448 K | 17,700 | Form 4 |
| filed | Klaus SchaferDirector | Option exercise | +60 | $2.400 | $144 | 8,960 | Form 4 |
| filed | Klaus SchaferDirector | Option exercise | +159 | $2.400 | $382 | 9,119 | Form 4 |
| filed | Klaus SchaferDirector | Option exercise | +60 | $2.400 | $144 | 9,179 | Form 4 |
| filed | David DrutzDirector | Buy | +1,000 | $8.000 | $8 K | 20,012 | Form 4 |
| filed | Vipin K. GargPresident and CEO, Director | Shares withheld for tax | -3,008 | $5.030 | $15 K | 280,818 | Form 4 |
| filed | David DrutzDirector | Buy | +1,200 | $4.500 | $5 K | 19,012 | Form 4 |
| filed | Vipin K. GargPresident and CEO, Director | Shares withheld for tax | -3,008 | $4.520 | $14 K | 283,826 | Form 4 |
| filed | Vipin K. GargPresident and CEO, Director | Shares withheld for tax | -3,007 | $6.050 | $18 K | 286,834 | Form 4 |
| filed | Matthew Scott HarrisChief Medical Officer | Option exercise | +30,000 | $1.920 | $58 K | 41,545 | Form 4 |
| filed | Matthew Scott HarrisChief Medical Officer | Sell10b5-1 plan | -30,000 | $7.520 | $226 K | 11,545 | Form 4 |
| filed | Vipin K. GargPresident and CEO, Director | Shares withheld for tax | -3,007 | $7.410 | $22 K | 289,841 | Form 4 |
| filed | Matthew Scott HarrisChief Medical Officer | Option exercise | +6,166 | — | — | 13,728 | Form 4 |
| filed | Vipin K. GargPresident and CEO, Director | Option exercise | +16,545 | — | — | 300,503 | Form 4 |
| filed | M. Scot RobertsChief Scientific Officer | Option exercise | +6,166 | — | — | 19,883 | Form 4 |
| filed | Matthew Scott HarrisChief Medical Officer | Shares withheld for tax | -2,183 | $7.980 | $17 K | 11,545 | Form 4 |
| filed | M. Scot RobertsChief Scientific Officer | Shares withheld for tax | -2,183 | $7.980 | $17 K | 17,700 | Form 4 |
| filed | Vipin K. GargPresident and CEO, Director | Shares withheld for tax | -7,655 | $7.980 | $61 K | 292,848 | Form 4 |
| filed | Matthew Scott HarrisChief Medical Officer | Grant or award | +1,800 | $6.860 | $12 K | 7,562 | Form 4 |
| filed | M. Scot RobertsChief Scientific Officer | Grant or award | +2,106 | $6.860 | $14 K | 13,717 | Form 4 |
| filed | Vipin K. GargPresident and CEO, Director | Grant or award | +2,757 | $6.860 | $19 K | 283,958 | Form 4 |
| filed | Vipin K. GargPresident and CEO, Director | Shares withheld for tax | -2,355 | $7.200 | $17 K | 281,201 | Form 4 |
| filed | David DrutzDirector | Option exercise | +70 | $2.400 | $168 | 17,882 | Form 4 |
| filed | John GillDirector | Gift | -2,714 | — | — | 0 | Form 4 |
| filed | Vipin K. GargPresident and CEO, Director | Shares withheld for tax | -3,007 | $8.930 | $27 K | 283,556 | Form 4 |
| filed | John GillDirector | Gift | -2,714 | — | — | 5,485 | Form 5 |
| filed | John GillDirector | Gift | -2,714 | — | — | 2,771 | Form 5 |
| filed | David DrutzDirector | Option exercise | +139 | $2.400 | $334 | 17,812 | Form 4 |
| filed | Vipin K. GargPresident and CEO, Director | Shares withheld for tax | -3,007 | $10.49 | $32 K | 286,563 | Form 4 |
| filed | David DrutzDirector | Option exercise | +70 | $2.400 | $168 | 17,673 | Form 4 |
| filed | Vipin K. GargPresident and CEO, Director | Shares withheld for tax | -3,007 | $10.80 | $32 K | 289,570 | Form 4 |
| filed | Vipin K. GargPresident and CEO, Director | Shares withheld for tax | -3,007 | $11.31 | $34 K | 292,577 | Form 4 |
| filed | Vipin K. GargPresident and CEO, Director | Shares withheld for tax | -3,008 | $14.09 | $42 K | 295,584 | Form 4 |
| filed | M. Scot RobertsChief Scientific Officer | Grant or award | +1,750 | $7.710 | $13 K | 11,611 | Form 4 |
| filed | William Michael BrownChief Financial Officer | Grant or award | +803 | $7.710 | $6 K | 17,721 | Form 4 |
| filed | Matthew Scott HarrisChief Medical Officer | Grant or award | +725 | $7.710 | $6 K | 5,762 | Form 4 |
| filed | Vipin K. GargPresident and CEO, Director | Shares withheld for tax | -3,007 | $9.070 | $27 K | 298,592 | Form 4 |
| filed | Vipin K. GargPresident and CEO, Director | Shares withheld for tax | -3,007 | $9.850 | $30 K | 301,599 | Form 4 |
| filed | Vipin K. GargPresident and CEO, Director | Shares withheld for tax | -2,577 | $12.65 | $33 K | 304,606 | Form 4 |
| filed | John GillDirector | Gift | -3,000 | — | — | 8,199 | Form 5 |
| filed | Vipin K. GargPresident and CEO, Director | Shares withheld for tax | -1,999 | $14.47 | $29 K | 307,183 | Form 4 |
| filed | Vipin K. GargPresident and CEO, Director | Shares withheld for tax | -1,998 | $13.55 | $27 K | 309,182 | Form 4 |
| filed | Philip HodgesDirector | Sell10b5-1 plan | -6,000 | $16.08 | $96 K | 8,731 | Form 4 |
| filed | Vipin K. GargPresident and CEO, Director | Shares withheld for tax | -1,998 | $15.94 | $32 K | 311,180 | Form 4 |
| filed | VHCP Management III, LLC10% owner | Otherindirect | -1.00 M | — | — | 3.50 M | Form 4 |
| filed | Vipin K. GargPresident and CEO, Director | Grant or award | +1,055 | $12.14 | $13 K | 313,178 | Form 4 |
| filed | Matthew Scott HarrisChief Medical Officer | Grant or award | +968 | $12.14 | $12 K | 5,037 | Form 4 |
| filed | William Michael BrownChief Financial Officer | Grant or award | +937 | $12.14 | $11 K | 16,918 | Form 4 |
| filed | M. Scot RobertsChief Scientific Officer | Grant or award | +467 | $12.14 | $6 K | 9,861 | Form 4 |
| filed | Vipin K. GargPresident and CEO, Director | Shares withheld for tax | -2,353 | $14.28 | $34 K | 312,123 | Form 4 |
| filed | Vipin K. GargPresident and CEO, Director | Shares withheld for tax | -3,025 | $11.30 | $34 K | 314,476 | Form 4 |
| filed | Klaus SchaferDirector | Buy | +2,000 | $11.99 | $24 K | 8,900 | Form 4 |
| filed | Philip HodgesDirector | Sell10b5-1 plan · indirect | -1,227 | $13.54 | $17 K | 0 | Form 4 |
| filed | Philip HodgesDirector | Sell10b5-1 plan | -2,500 | $12.00 | $30 K | 14,731 | Form 4 |
| filed | Vipin K. GargPresident and CEO, Director | Shares withheld for tax | -2,243 | $12.23 | $27 K | 317,501 | Form 4 |
| filed | John GillDirector | Sell10b5-1 plan | -8,425 | $11.92 | $100 K | 11,199 | Form 4 |
| filed | David DrutzDirector | Option exercise | +60 | $2.400 | $144 | 17,603 | Form 4 |
| filed | Matthew Scott HarrisDirector | Sell10b5-1 plan | -4,015 | $10.02 | $40 K | 4,069 | Form 4 |
| filed | Klaus SchaferDirector | Sell10b5-1 plan | -10,150 | $9.910 | $101 K | 6,900 | Form 4 |
| filed | Wayne PisanoDirector | Sell10b5-1 plan | -10,352 | $9.900 | $102 K | 8,498 | Form 4 |
| filed | Vipin K. GargPresident and CEO, Director | Shares withheld for tax | -2,015 | $11.45 | $23 K | 319,744 | Form 4 |
| filed | Vipin K. GargPresident & CEO, Director | Shares withheld for tax | -2,015 | $13.20 | $27 K | 321,759 | Form 4 |
| filed | Philip HodgesDirector | Option exercise | +16,850 | — | — | 36,306 | Form 4 |
| filed | Wayne PisanoDirector | Option exercise | +16,850 | — | — | 18,850 | Form 4 |
| filed | John GillDirector | Option exercise | +16,850 | — | — | 19,624 | Form 4 |
| filed | Klaus SchaferDirector | Option exercise | +16,850 | — | — | 17,050 | Form 4 |
| filed | David DrutzDirector | Option exercise | +16,850 | — | — | 17,543 | Form 4 |
| filed | Mitchel SayareDirector | Option exercise | +25,275 | — | — | 26,363 | Form 4 |
| filed | Vipin K. GargPresident & CEO, Director | Shares withheld for tax | -2,015 | $17.62 | $36 K | 323,774 | Form 4 |
| filed | Matthew Scott HarrisChief Medical Officer | Grant or award | +8,084 | $1.460 | $12 K | 8,084 | Form 4 |
| filed | M. Scot RobertsChief Scientific Officer | Grant or award | +3,859 | $1.460 | $6 K | 9,394 | Form 4 |
| filed | William Michael BrownChief Financial Officer | Grant or award | +7,920 | $1.460 | $12 K | 15,981 | Form 4 |
| filed | Vipin K. GargChief Financial Officer, Director | Grant or award | +11,674 | $1.460 | $17 K | 325,789 | Form 4 |
| filed | Vipin K. GargPresident and CEO, Director | Shares withheld for tax | -2,015 | $26.06 | $53 K | 314,115 | Form 4 |
| filed | Vipin K. GargPresident and CEO, Director | Shares withheld for tax | -2,015 | $10.71 | $22 K | 316,130 | Form 4 |
| filed | VHCP Co-Investment Holdings II, LLC10% owner | Buyindirect | +1.50 M | $7.540 | $11.3 M | 4.50 M | Form 4 |
| filed | Vipin K. GargPresident and CEO, Director | Shares withheld for tax | -2,015 | $9.280 | $19 K | 318,145 | Form 4 |
| filed | VHCP Management III, LLC10% owner | Buyindirect | +27,763 | $7.790 | $216 K | 2.83 M | Form 4 |
| filed | VHCP Management III, LLC10% owner | Buyindirect | +173,711 | $8.870 | $1.5 M | 3.00 M | Form 4 |
| filed | VHCP Management III, LLC10% owner | Buyindirect | +125,162 | $7.230 | $905 K | 2.52 M | Form 4 |
| filed | VHCP Management III, LLC10% owner | Buyindirect | +277,000 | $7.920 | $2.2 M | 2.80 M | Form 4 |
| filed | VHCP Management III, LLC10% owner | Buyindirect | +309,453 | $8.790 | $2.7 M | 2.01 M | Form 4 |
| filed | VHCP Management III, LLC10% owner | Buyindirect | +390,547 | $9.780 | $3.8 M | 2.40 M | Form 4 |
| filed | Velocity Pharmaceutical Holdings LLC10% owner | Sell | -30,622 | $4.650 | $142 K | 1.69 M | Form 4 |
| filed | Velocity Pharmaceutical Holdings LLC10% owner | Sell | -169,378 | $4.810 | $815 K | 1.72 M | Form 4 |
| filed | Vipin K. GargPresident and CEO, Director | Shares withheld for tax | -2,015 | $3.050 | $6 K | 320,160 | Form 4 |
| filed | Vipin K. GargPresident and CEO, Director | Shares withheld for tax | -2,016 | $3.020 | $6 K | 322,175 | Form 4 |
| filed | Vipin K. GargPresident and CEO, Director | Shares withheld for tax | -2,015 | $3.700 | $7 K | 324,191 | Form 4 |
| filed | Vipin K. GargPresident and CEO, Director | Grant or award | +11,289 | $1.460 | $16 K | 326,206 | Form 4 |
| filed | William Michael BrownChief Financial Officer | Grant or award | +8,061 | $1.460 | $12 K | 8,061 | Form 4 |
| filed | M. Scot RobertsChief Scientific Officer | Grant or award | +3,698 | $1.460 | $5 K | 5,535 | Form 4 |
| filed | Vipin K. GargPresident and CEO, Director | Shares withheld for tax | -2,015 | $1.770 | $4 K | 314,917 | Form 4 |
| filed | Vipin K. GargPresident and CEO, Director | Shares withheld for tax | -1,999 | $1.800 | $4 K | 316,932 | Form 4 |
| filed | Vipin K. GargPresident and CEO, Director | Shares withheld for tax | -23,976 | $1.820 | $44 K | 318,931 | Form 4 |
| filed | Vipin K. GargPresident and CEO, Director | Buy | +20,000 | $2.100 | $42 K | 342,907 | Form 4 |
| filed | Vipin K. GargPresident and CEO, Director | Grant or award | +322,907 | — | — | 322,907 | Form 4 |
| filed | Wayne PisanoDirector | Buy | +2,000 | $4.590 | $9 K | 2,000 | Form 4 |
| filed | Novartis Bioventures Ltd10% owner | Otherindirect | +2.07 M | — | — | 8.35 M | Form 4 |
| filed | Ag Novartis10% owner | Otherindirect | +663,346 | — | — | 6.28 M | Form 4 |
| filed | Novartis Bioventures Ltd10% owner | Otherindirect | +14,449 | — | — | 5.61 M | Form 4 |
| filed | Ag Novartis10% owner | Otherindirect | +720,878 | — | — | 5.60 M | Form 4 |
| filed | William EnrightPresident and CEO, Director | Buy | +1,300 | $0.510 | $663 | 365,839 | Form 4 |
| filed | M. Scot RobertsChief Scientific Officer | Option exercise | +55,120 | $0.080 | $4 K | 55,120 | Form 4 |
| filed | Ag Novartis10% owner | Otherindirect | +767,728 | — | — | 4.88 M | Form 4 |
| filed | Ag Novartis10% owner | Otherindirect | +274,703 | — | — | 4.11 M | Form 4 |
| filed | Novartis Bioventures Ltd10% owner | Otherindirect | +482,907 | — | — | 3.62 M | Form 4 |
| filed | Novartis Bioventures Ltd10% owner | Otherindirect | +217,159 | — | — | 3.83 M | Form 4 |
| filed | Novartis Bioventures Ltd10% owner | Otherindirect | +261,969 | — | — | 3.13 M | Form 4 |
| filed | Novartis Bioventures Ltd10% owner | Otherindirect | +67,925 | — | — | 2.87 M | Form 4 |
| filed | Capital S.a.s. Truffle10% owner | Otherindirect | +4,483 | — | — | 179,427 | Form 4 |
| filed | Capital S.a.s. Truffle10% owner | Otherindirect | +5,977 | — | — | 139,184 | Form 4 |
| filed | Capital S.a.s. Truffle10% owner | Otherindirect | +4,483 | — | — | 76,700 | Form 4 |
| filed | Novartis Bioventures Ltd10% owner | Otherindirect | +269,527 | — | — | 2.80 M | Form 4 |
| filed | Capital S.a.s. Truffle10% owner | Otherindirect | +17,789 | — | — | 174,944 | Form 4 |
| filed | Capital S.a.s. Truffle10% owner | Otherindirect | +23,719 | — | — | 133,207 | Form 4 |
| filed | Capital S.a.s. Truffle10% owner | Otherindirect | +17,789 | — | — | 72,217 | Form 4 |
| filed | Novartis Bioventures Ltd10% owner | Otherindirect | +176,586 | — | — | 2.53 M | Form 4 |
| filed | Capital S.a.s. Truffle10% owner | Otherindirect | +11,655 | — | — | 157,155 | Form 4 |
| filed | Capital S.a.s. Truffle10% owner | Otherindirect | +15,541 | — | — | 109,488 | Form 4 |
| filed | Capital S.a.s. Truffle10% owner | Otherindirect | +11,655 | — | — | 54,428 | Form 4 |
| filed | William EnrightPresident and CEO, Director | Option exercise | +183,347 | $0.080 | $15 K | 364,511 | Form 4 |
| filed | Mitchel SayareDirector | Buyindirect | +5,100 | $1.950 | $10 K | 32,650 | Form 4 |
Source: SEC Forms 4 and 5. A trade under a 10b5-1 plan was scheduled in advance. For information only; not investment advice